| Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) (NCT05308966) | Groupe Francais De Pneumo-Cancerologie | 2022-05-03 |
| Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors (NCT04870879) | Azienda Ospedaliera di Padova | 2020-10-01 |
| A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer (NCT04207918) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-11-14 |
| Chemoradiotherapy in Unresectable Esophageal Cancer (NCT04278287) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2019-10-01 |
| ImmunoPET With an Anti-CD8 Imaging Agent (NCT04029181) | University Medical Center Groningen | 2019-02-14 |
| Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer (NCT03777813) | UNICANCER | 2018-12-05 |
| QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. (NCT03647423) | ImmunityBio, Inc. | 2018-08-31 |
| A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors (NCT03238027) | Syndax Pharmaceuticals | 2017-09-01 |
| Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer (NCT03240861) | Jonsson Comprehensive Cancer Center | 2017-07-26 |
| Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors (NCT03108131) | M.D. Anderson Cancer Center | 2017-04-07 |
| Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery (NCT02583269) | Wake Forest University Health Sciences | 2016-03-01 |
| Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery (NCT02540876) | University of Chicago | 2015-09-08 |
| Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma (NCT02306850) | St. Louis University | 2015-01-01 |
| Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain (NCT01846429) | H. Lee Moffitt Cancer Center and Research Institute | 2013-09-01 |
| Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC (NCT01963351) | University of Athens | 2012-01-01 |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT01366144) | National Cancer Institute (NCI) | 2011-06-20 |